Mariner’s Cidara Therapeutics CDTX Stock Holding History

Mariner’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,700	Closed	-$376K	–	3599
2025 Q4	$376K	Buy	+1,700	New	+$275K	﹤0.01%	2662
2024 Q2	–	Sell	-500	Closed	-$9.2K	–	3189
2024 Q1	$9.2K	Buy	+500	New	+$7.18K	﹤0.01%	3116

Mariner's CDTX Position: Q1 2026 in Review

Mariner sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 1,700 shares — an estimated $376K sold.

Mariner first reported a position in CDTX in Q1 2024 and held it in 2 quarters. The position peaked at $376K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Mariner reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Mariner sold 1,700 Cidara Therapeutics shares in Q1 2026, an estimated $376K.
Mariner first reported a position in Cidara Therapeutics in Q1 2024 and held it in 2 quarters.
Mariner's Cidara Therapeutics position peaked at $376K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.